New effort will get genome sequences for entire Endangered Species list

In a groundbreaking announcement, a significant collaboration is set to take place that aims to sequence the genomes of all species listed under the US Endangered Species Act. This act mandates governmental action to identify and protect vulnerable species, ensuring their survival and the preservation of their habitats. While the initiative has seen remarkable achievements—such as the recovery of the bald eagle—over 2,300 plant and animal populations still require active intervention. The upcoming genomic sequencing and tissue preservation efforts will be spearheaded by an unusual partnership between the US government and Colossal Biosciences, a biotech firm known for its controversial stance on species conservation. Historically, the government has taken steps to diminish the Endangered Species Act in its regulatory agenda. Yet, this new collaboration suggests a shift towards more proactive conservation strategies. Colossal Biosciences, while primarily recognized for its audacious projects aimed at resurrecting extinct species through gene editing, has asserted its commitment to conservation. However, skepticism remains about its true dedication, especially following its recent announcement concerning the dire wolf, which involved minimal genetic modifications to existing grey wolves. This partnership, while ambitious, will undoubtedly face scrutiny as it embarks on this vital quest to safeguard the future of endangered species through genetic technology.